CIK 0000725363
- Non-accelerated filer
- Smaller reporting company
CEL SCI CORP
Sign in to watch- Ticker
- CVM
- Exchange
- NYSE
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Sep 30
- Incorporated
- CO
- Entity type
- Operating
- EIN
- 840916344
- Phone
- +1 703-506-9460
- Business address
- 8229 BOONE BLVD ., SUITE 802, VIENNA, VA, 22182
- 4 Grant or award Chief Executive Officer acquired 483 shares (grant or award)
- 4 Open-market buy Chief Executive Officer bought 3,725 shares at $6.71 ($24,995)
- 4 Grant or award Senior Vice President acquired 382 shares (grant or award)
- 4 Grant or award Chief Scientific Officer acquired 268 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 410 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 461 shares (grant or award)
- 4 Open-market sale Senior Vice President sold 8,000 shares at $8.69 ($69,559)
- 4 Grant or award Senior Vice President acquired 2,375 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 2,095 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 3,492 shares (grant or award)
- 4 Open-market sale Senior Vice President sold 8,000 shares at $7.03 ($56,208)
- 4 Grant or award Chief Executive Officer acquired 6,631 shares (grant or award)
- 4 Open-market buy Director bought 2,000 shares at $5.00 ($10,000)
- 4 Grant or award Director acquired 1,458 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 4,373 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 2,915 shares (grant or award)
- 4 Grant or award Senior Vice President acquired 7,289 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 14,577 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 10 of 41 · 806 filings